| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.082 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |